Abstract
Human leucocyte antigen-G (HLA-G) is a non-classical HLA class I molecule with an important role at the fetus-maternal interface, preventing fetus recognition and abortion. The role of HLA-G as an immune-modulatory and anti-inflammatory molecule has led to investigate its role in pathological conditions. In these years, HLA-G has been shown to have an important implication in inflammatory pathologies. The focus of this review is to up-date the scientific knowledge on the expression of HLA-G molecules in inflammatory conditions.
Keywords: HLA-G, immunity, immune cells, inflammation, pathology, regulation, Human leucocyte antigen-G, anti-inflammatory, HLA-G typing, Allergic disorders
Inflammation & Allergy - Drug Targets (Discontinued)
Title:New Insights into HLA-G and Inflammatory Diseases
Volume: 11 Issue: 6
Author(s): Roberta Rizzo, Daria Bortolotti, Olavio R. Baricordi and Enrico Fainardi
Affiliation:
Keywords: HLA-G, immunity, immune cells, inflammation, pathology, regulation, Human leucocyte antigen-G, anti-inflammatory, HLA-G typing, Allergic disorders
Abstract: Human leucocyte antigen-G (HLA-G) is a non-classical HLA class I molecule with an important role at the fetus-maternal interface, preventing fetus recognition and abortion. The role of HLA-G as an immune-modulatory and anti-inflammatory molecule has led to investigate its role in pathological conditions. In these years, HLA-G has been shown to have an important implication in inflammatory pathologies. The focus of this review is to up-date the scientific knowledge on the expression of HLA-G molecules in inflammatory conditions.
Export Options
About this article
Cite this article as:
Rizzo Roberta, Bortolotti Daria, R. Baricordi Olavio and Fainardi Enrico, New Insights into HLA-G and Inflammatory Diseases, Inflammation & Allergy - Drug Targets (Discontinued) 2012; 11 (6) . https://dx.doi.org/10.2174/187152812803590037
DOI https://dx.doi.org/10.2174/187152812803590037 |
Print ISSN 1871-5281 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4055 |
Related Articles
-
Assessing Coronary Blood Flow Physiology in the Cardiac Catheterisation Laboratory
Current Cardiology Reviews Aldosteronism in Heart Failure: A Proinflammatory / Fibrogenic Cardiac Phenotype. Search for Biomarkers and Potential Drug Targets
Current Drug Targets Multimodality Imaging for Interventional Cardiology
Current Pharmaceutical Design Sarcoidosis in Pregnancy and Postpartum Period
Current Respiratory Medicine Reviews Impact of N-acetylcysteine and Etodolac Treatment on Systolic and Diastolic Function in a Rat Model of Myocardial Steatosis Induced by High-Fat-Diet
Endocrine, Metabolic & Immune Disorders - Drug Targets Carnitine Metabolism and Deficit - When Supplementation is Necessary?
Current Pharmaceutical Biotechnology Insight γ-Secretase: Structure, Function, and Role in Alzheimer’s Disease
Current Drug Targets Anaphylaxis in Risky Populations
Current Pharmaceutical Design The Two Faces of Iminoalditols: Powerful Inhibitors Trigger Glycosidase Activation
Current Enzyme Inhibition Mouse Models of Autoimmune Diseases - Autoimmune Myocarditis
Current Pharmaceutical Design The Role of Stem Cells in Muscular Dystrophies
Current Gene Therapy Oxidative Stress and Mitochondrial Impairment After Treatment with Anti-HIV Drugs: Clinical Implications
Current Pharmaceutical Design Microbubbles: Revolutionizing Biomedical Applications with Tailored Therapeutic Precision
Current Pharmaceutical Design Congenital Hypothyroidism: Facts, Facets & Therapy
Current Pharmaceutical Design Chronic Heart Failure- Potential for Pharmacological Intervention
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Future Therapeutic Strategies in Inflammatory Cardiomyopathy: Insights from the Experimental Autoimmune Myocarditis Model
Cardiovascular & Hematological Disorders-Drug Targets MicroRNA 21 Emerging Role in Diabetic Complications: A Critical Update
Current Diabetes Reviews The Woman’s Heart: Insights into New Potential Targeted Therapy
Current Medicinal Chemistry Gene Therapy Approaches for Cardiovascular Diseases
Current Gene Therapy Pharmacogenetically Tailored Treatments for Heart Disease
Current Pharmaceutical Design